Don't miss

Replay


LATEST SHOWS

THE DEBATE

Macron in Washington: Can he change Trump's Foreign Policy?

Read more

FOCUS

Catalonia's pro-independence movement tempted by radicalisation

Read more

ENCORE!

Film show: 'May ’68', Director’s Fortnight reloaded, 'A Paris Education'

Read more

IN THE PRESS

Macron and Trump: Dandruff diplomacy?

Read more

PERSPECTIVE

Big data: ‘A key democratic issue’

Read more

MIDDLE EAST MATTERS

Susan Meiselas: Kurdistan through the lens

Read more

BUSINESS DAILY

Global wine production drops to lowest level in 60 years

Read more

MEDIAWATCH

Trump and Macron media moments in the US

Read more

ENCORE!

Photographer Clare Strand explores the causes and consequences of communication breakdown

Read more

Business

GSK to cut 4,000 jobs in Europe and US

Text by News Wires

Latest update : 2010-01-31

Despite rising profits, British pharmaceuticals company GlaxoSmithKline is expected to announce a cut up to 4,000 more jobs. Most of the jobs cut will be in the United States and Europe.

AFP - British pharmaceuticals giant GlaxoSmithKline is to cut up to 4,000 more jobs as it restructures its workforce and focuses increasingly on emerging markets, The Sunday Times reported.
   
The majority of the jobs will be lost in the United States and Europe, the newspaper said.
   
GSK, which employs just under 100,000 staff globally, is expected to reveal plans for the job cuts when it releases its annual results on Thursday, the report said.
   
Its Anglo-Swedish rival AstraZeneca announced on Thursday it plans to axe 8,000 more jobs worldwide by 2014, extending a cost-cutting drive despite soaring profits.
   
While GSK is still seeking to develop new drugs, it is increasingly turning to emerging markets to find growth.
   
This led to it recently cutting 2,000 sales jobs in the United States while adding 1,500 staff in China.
   
The big players in the global pharmaceuticals industry are seeing their profits squeezed as they reduce their reliance on top-selling blockbuster drugs, many of whose patents will soon expire.

Date created : 2010-01-31

  • BENIN

    Chirac joins African leaders in calling for ban on fake drug sales

    Read more

COMMENT(S)